Background:Transrectal ultrasound is commonly performed in the clinical evaluation of the prostate. Ultrasound-guided randomized sextant biopsy became the standard procedure for the diagnosis of carcinoma of the prostate (CaP). A guided biopsy of sonographically irregular lesions of the prostate is not performed in randomized biopsies. An almost generally accepted opinion is that hypoechoic lesions are suspicious for the presence of CaP. However, the role of prostatic lesions with an echogenicity other than iso-or hypoechoic, e. g. hyperechoic or irregular lesions in relation to CaP is not clear. The intention of the present prospective study was to clarify the role of different prostatic ultrasound findings with a new-generation ultrasound probe in regard to their relevance concerning the presence of cancer. Material and Methods: 265 patients who were referred for prostatic evaluation because of an elevated PSA serum level or a positive digital rectal examination were enrolled in a prospective study. All patients had a systematic ultrasound-guided sextant biopsy of the prostate and a 4-core biopsy of the transition zone. All biopsy cores taken were guided by transrectal ultrasound. In case of a sonographically suspicious lesion, biopsy was always directed into this area. The predominant ultrasound appearance was separately recorded for each core. Results: Carcinoma of the prostate was detected in 87 (32.8%) of the 265 patients. Biopsy cores with isoechoic ultrasound findings revealed CaP in 7.6%. The data for hypoechoic, hyperechoic, mixed-echoic and anechoic lesions were 34.5, 26.9, 21.1 and 0%, respectively. Hypoechoic ultrasound findings were less frequently found in the transition zone of the prostate, but the rate of CaP detection was the same as in the peripheral zone of the prostate. Conclusions: The transrectal ultrasound pattern of the prostate yields important information about the presence of carcinoma of the prostate. Especially hypoechoic lesions indicate the presence of CaP in a significant proportion of cases. However, hyperechoic lesions and lesions of mixed or irregular echogenicity were found to contain cancer in significant numbers as well, and should therefore be considered to be suspicious for cancer when performing transrectal ultrasound of the prostate. Directed biopsy of irregular ultrasound patterns in the prostate seems therefore to be recommendable.
Zusammenfassung
Hintergrund: Der transrektale Ultraschall ist die häufigste bildgebende Untersuchung zur klinischen Beurteilung der Prostata. Zur Diagnostik des Prostatakarzinoms (PCa) hat sich die ultraschallgesteuerte Sextanten-Biopsie als Standardverfahren etabliert. Eine gezielte Biopsie irregulärer Ultraschallbezirke ist hier nicht vorgesehen. Es ist jedoch bekannt, daß sonographisch echoarm erscheinende Areale suspekt für die Präsenz eines PCa sind. Die Wertigkeit nicht einheitlicher oder echoreicher Ultraschallmuster ist jedoch bisher nicht zweifelsfrei geklärt. Ziel der vorliegenden Arbeit war es, mit einem Ultraschallgerät der neuesten Generation die Bedeutung der verschiedenen Ultraschallmuster bezüglich des Vorhandenseins von Prostatakarzinomen zu klären. 
Material und

Introduction
In the early 1980s, cancer of the prostate (CaP) was believed to have a hyperechoic appearance in transrectal ultrasound (TRUS) [1] [2] [3] . In 1985, Lee and co-workers [4] , however, demonstrated that CaP in the peripheral zone has a predominantly hypoechoic ultrasound pattern. These findings were confirmed by other investigators [5, 6] . In the meantime, further technical (ultrasound consoles) and diagnostic improvements (TRUS-guided biopsy, systematic sextant biopsy, transition zone biopsy) were made. Especially PSA-based screening programs led to an increase in the number of CaPs detected and to an increase of patients subjected to biopsy.This resulted in a stage shift from more advanced CaP towards T2 and nonpalpable T1c CaP. However, there is a large number of patients with benign histologies on systematic sextant biopsies of the peripheral zone (65.6-82.1%) [7, 8] . In such cases, further biopsies may reveal the presence of CaP in up to 21% according to Keetch et al. [9] .A more differentiated use of biopsy techniques with ultrasound diagnostic could be helpful in reducing the number of unnecessary (primary and further) prostatic biopsies and would increase the number of CaPs detected. Therefore, in the present prospective study all isoechoic and suspicious lesions in peripheral and transition zone TRUS were analyzed in relation to the rate of CaPs detected.
Materials and Methods
Between September 1997 and July 1999, 265 men referred for systematic prostate biopsy were included in this prospective study. Indications for prostate biopsy were an elevation of the PSA value in serum (PSA ≥ 4 ng/ ml; n = 238) and/or a digital rectal examination (DRE) suspicious for CaP (n = 99). Serum PSA levels were determined before any rectal manipulations with the Abbott AxSym enzyme immunoassay (Abbott, Wiesbaden, Germany). DRE was performed, and the findings were classified as benign, benignly enlarged or suspect. Urinary examination was carried out in all patients. Patients with urinary tract infections were treated by antibiotics corresponding to urinary culture and sensitivity testing. The prostate biopsy was postponed in all cases of urinary tract infections. In all other patients, ciprofloxacin (2 × 250 mg b.d.) was administered for 5 days as a prophylactic antibiotic treatment, beginning 2 days before the biopsy. Careful counseling relative to the possible complications was carried out, and both verbal and written consent was obtained. All men underwent real-time transrectal ultrasound using a Siemens Versa (7.5-MHz biplanar) ultrasound probe (Siemens, Erlangen, Germany). Each prostate was examined in sagittal and axial projections. The distinction between peripheral and transition zones was recognizable in all cases. Core biopsies were obtained using an automatic biopsy device (Urotech, Bruckmühl, Germany). From each lobe 5 cores were taken: 3 cores from the peripheral zone (apex, midgland and base of the prostate) according to the systematic sextant biopsy technique described previously by Hodge et al. [10] , and 2 from the transition zone. If there was a suspicious ultrasound finding, the biopsy needle was directed into this area. For each core taken, the predominant ultrasound pattern was recorded and classified as isoechoic, hypoechoic, hyperechoic or anechoic. Areas of non-uniform ultrasound patterns were classified as mixed-echoic. Biopsy specimens were processed separately and evaluated for the presence of CaP. All tumors were classified according to the TNM classification of 1997 [11] . Statistical analysis was carried out with 'SPSS for Windows' 8.0. Distribution of variance was tested with the chi-square test. A univariate ANOVA was done, and differences in means were analyzed with the Scheffé and Tamhane procedure. The level of significance was set at 5% probability of error.
Results
The mean PSA serum level of all patients was 40.89 (median 8.3) ng/ml, with a range of 0.4 to 3,773 ng/ml. Histological examination was done in all cases and revealed the presence of CaP in 87 of 265 patients (32.8%). Tumor stages were classified as T1c (n =19), T2 (n = 43), T3 (n =18), and T4 (n = 7). According to the TNM classification of 1997, 20 of the 43 T2 tumors had a negative rectal finding but TRUS was suspicious for CaP, and 23 patients had a positive DRE. In the 87 patients with CaP, 4.02 core biopsies were positive on average (range 1-10). In 27 patients (31%), CaP was present in the peripheral zone only. In 5 patients (5.8%), CaP was histologically confirmed in the transition zone only, and 55 cancers (63.2%) were found in both peripheral and transition zones. The results of the ultrasonographic examination and the corresponding histological findings for each biopsy core are presented in table 1. Biopsies taken from tissue with isoechoic pattern revealed CaP in 7.6% of cases only, whereas a hypoechoic lesion was associated with CaP in 34.5% of all biopsy cores. In addition, biopsy cores taken from regions with hyperechoic or mixed-echoic appearance were also connected with the presence of CaP in a significant proportion (26.9 and 21.1%, respectively). In contrast, biopsies taken from cystic lesions never revealed CaP (table 1) . Regarding statistical analysis, a significant correlation between histological result (benign histology, prostatic intraepithelial neoplasia (PIN), CaP) and ultrasound appearance of the prostatic tissue biopsied was found (chi-square test p = 0.000, ⌾ 2 = 245.72; contingency coefficient = 0.291). Univariate analysis of variance showed also a significant difference in mean group values for histology and for the number of different ultrasound findings (isoechoic, hypoechoic, hyperechoic, mixed-echoic, anechoic). The Scheffé and Tamhane procedure showed also a significant difference for mean values for histologically benign and CaP results (p = 0.000), but not for PIN findings (p = 0.849). In tables 2 and 3 the results for the patients with positive or negative DRE are demonstrated. A significant correlation between histological results and ultrasound patterns was found in patients with suspicious DRE (chi-square test p = 0.000, ⌾ 2 = 259.51; contingency coefficient = 0.308). Univariate analysis of variance showed a significant difference in mean group values for the benign histology, PIN and CaP for the number of different ultrasound findings (p = 0.000) ( hypoechoic lesions, a CaP was detected. In 45 of these 54 patients, CaP was histologically confirmed in hypoechoic lesions, and in 9 of the 54 patients the localization of the CaP was other than in the hypoechoic lesion. The presence of a hypoechoic lesion in the peripheral or transition zone only was associated with a CaP in a corresponding biopsy core in 29.7% and 20%, respectively. If hypoechoic lesions were present in both peripheral and transition zones, a CaP was detected in 59.5%.The mean number of biopsy cores with a hypoechoic ultrasound pattern was 0.84 ±1.3 in patients with a benign histology vs 1.8 ±1.98 in patients with CaP. In all patients with CaP, an average of 4.2 biopsy cores was taken from suspicious lesions (hypoechoic, hyperechoic or mixed-echoic) ( fig. 1 ). In patients with benign histology, only 2.2 biopsy cores showed sonographically suspicious lesions.
Discussion
Randomized sextant biopsy of the prostate as described by Hodge et al. [10] in 1989 was established as the standard diagnostic procedure in the evaluation of patients with the suspicion of CaP. However, as many as 41.5% of significant CaPs may be missed by one set of prostatic biopsies, as could be demonstrated by Djavan et al. [12] who performed two consecutive sets of prostatic biopsies in a group of 1,051 patients (PSA serum levels 4-10 ng/ml). Efforts have therefore been made to improve the detection rate of the systematic sextant biopsy of the prostate and to reduce the number of secondary prostatic biopsies. Under investigation is the modification of the number and site of core biopsies taken [13, 14] , and mathematical models for the correct number of core biopsies per patient were established [15] . In this prospective study, extended systematic sextant biopsies of the prostate -extended with 4 additional biopsies of the transition zone -were done on patients with a suspicion of CaP. In the study performed herein, biopsy was ultrasoundguided, and if irregular ultrasound findings were present, biopsy cores were directly taken from the suspicious lesion. This is in contrast to the standard sextant biopsy technique, where ultrasound is only used to receive randomized biopsy cores. For each biopsy core, the predominant ultrasound pattern was documented and analyzed in relation to the histological result of the corresponding biopsy core.The intention of the present study was to evaluate the importance of prostatic ultrasound findings other than isoechoic. It is generally accepted that prostatic biopsy is indicated in patients with a PSA elevation > 4 ng/ml or with palpable abnormalities of the prostate. In addition, it is accepted that hypoechoic areas that can be recognized on transrectal ultrasound examination of the prostate are often associated with the presence of CaP. The mere presence of any hypoechoic lesions in the peripheral zone is stated to be associated with a sensitivity of 86% and a specificity of 45% for the detection of CaP [5] . Considering TRUS as suspicious when a hypoechoic lesion was present anywhere in the prostate, the sensitivity of hypoechoic lesions for the presence of CaP was 62.1% and the specificity was 57.3% in the present study. Analysis for each core biopsy with isoechoic ultrasound pattern revealed CaP in 7.6% of biopsy cores only, whereas an echogenicity other than isoechoic was associated with a much higher rate of CaP detected (table 1) . Cancer diagnosis was increased most when biopsying hypoechoic lesions with a detection rate of 34.5%. But also taking biopsies from regions of hyperechoic or mixedechoic ultrasound appearance resulted in the detection of CaP in 26.9 and 21.1%, respectively. TRUS findings were examined in relation to DRE results by Devonec et al. [16] . In that study, 64 patients had a palpable nodularity on DRE, and CaP was found in 34 patients (53% . In all 835 cases guided biopsies of the suspicious lesions were performed, and CaP was found in 263 patients (31.5%); 260 of these lesions were identified in the peripheral or central zones, whereas only 3 cases (1.1%) of CaP could be detected in the transition zone. This is in contrast to our study, in which 22.6% of the 265 patients had hypoechoic lesions in the transition zone, who were classified to be suspicious for CaP. In 48.3% of these patients, biopsy proved positive for CaP. Supported by the data of McNeal et al. [18] who showed that CaP develops in the transition zone in about 24% of all prostatic carcinomas, the number of CaPs detected in the transition zone seems to be rather low and perhaps may be ascribed to the transition zone biopsy technique used by Cooner and co-workers [6] . In most studies, however, randomized transition zone biopsies were performed and suspicious areas were not directly biopsied as the transition zone is somewhat more hypoechoic in comparison to the peripheral zone. In the present study, pronounced hypoechoic ultrasound patterns were found less frequently in the transition zone than in the peripheral zone, but hypoechoic lesions were associated with CaP in the transition zone in 20% and in the peripheral zone in 29.7%. Under the condition that hypoechoic lesions were present in both peripheral and transition zones, CaP was detected in 59.5%. In our opinion, pronounced hypoechoic lesions in the transition zone therefore have to be taken into account when suspecting CaP. The present study also shows a high number of CaP in hyperechoic and echo-mixed/irregular lesions. Although there are some studies in which hyperechoic areas have been found to be associated with CaP, exact data with new ultrasound technique are not available. The majority of examiners assess only hypoechoic areas as suspicious for CaP. Most prostate biopsy studies do not directly relate to the echogenicity of the prostatic tissue, and it is not always clear whether all suspicious prostatic lesions or hypoechoic lesions only were biopsied. In the present study all suspicious lesions, i.e. areas appearing not isoechoic, were biopsied, and in all patients 10 core biopsies, representative of the peripheral and the transition zone, were taken. As a result, the number of lesions per prostate classified as of hypo-, hyper-or mixed-echoic appearance could be identified as predictive for CaP. Thus, when taking into account all suspicious ultrasound patterns and the number found in each patient, this could be helpful in avoiding repeated unnecessary prostatic biopsies.
In conclusion, echogenicity in prostatic ultrasound is highly informative, and guided biopsies may increase the rate of CaP detected. Although hypoechoic lesions in transrectal ultrasound are most often associated with the presence of CaP, hyperechoic lesions and lesions with a mixed/irregular ultrasound appearance contain the 3-to 4-fold number of CaP in comparison to isoechoic (normal) prostatic tissue. In addition, transition zone ultrasound shows hypoechoic lesions less frequently, but when seen, transition zone hypoechogenicity is associated with CaP in nearly the same frequency as in the peripheral zone. From our data, directed biopsies of irregular ultrasound findings with a modern ultrasound equipment seem to be advisable to increase the detection rate of CaP.
